hotspot -WSS

hotspot

author：explore 2025-10-02 10:48:24 - browse：998

A display of TVs against an orange background. -- health policy coverage from STAT — Adobe

WASHINGTON — Government regulators may soon decide whether to crack down on distracting visuals in television drug commercials or require subtitles about side effects, a regulation that’s been 13 years in the making.

White House budget experts are reviewing changes to the regulation of broadcast drug advertisements that the Food and Drug Administration proposed in 2010, according to the Office of Management and Budget website. That proposal aimed to make commercials present drug risks in a manner that consumers notice and understand.

Drug ads have long been controversial. Aside from New Zealand, the United States is the only country that allows drug makers to advertise to consumers. Critics of drug ads say they pose consumer safety concerns by bombarding the public with promotions that distract viewers from potential side effects. Drug companies say commercials spark conversations between patients and doctors that promote clinically beneficial prescribing.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Bright Health sells Medicare Advantage business to Molina
Next article： CDC backtracks, saying fully vaccinated people can go maskless indoors

leisure time

WSS

Heart disease and mental health: A look at cardiac psychology

The SUPPORT Act is critical to fighting the opioid crisis

FDA official pushes for dedicated emerging pathogens team

Biotech reporter’s notebook: A sunnier mood at JPM 2024

In new study, freeze

In new study, freeze

focus

hotspot

hotspot

Affirmative action in medical school literally saved lives

GSK to buy asthma

FDA approval of Sarepta Duchenne genetic therapy gives me hope

What to know about Saharan dust affecting the US and how it can affect health

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

JPM 2024: Nvidia claims we're in biological revolution. Are we?

DIEP, the 'gold standard' of breast reconstruction, is under threat

JPM 2024: FogPharma’s CEO unveils ‘contrarian’ plan in oncology

The high cost of giving birth even with insurance

New rules on organ donation and transplantation 'will bring chaos'

entertainment

Death toll from an explosion and collapse of a Paris building in June climbs to 3

CDC backtracks, saying fully vaccinated people can go maskless indoors

Contact tracing may help avoid another lockdown. Can it work in the U.S.?

Why liver experts renamed NASH to MASH, and NAFLD to MASLD

Fauci’s Covid grilling leads GOP to weigh foreign research rules

Biotech reporter’s notebook: A sunnier mood at JPM 2024

leisure time

Wikipedia

explore

hotspot